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Evaluating the Role of Preoperative Breast MRI in Improving 
 Diagnostic Accuracy of Breast Cancer Patients
Christine Xue, MD, Jennifer Macfarlan, MPH, Priya Sareen, MD
Lehigh Valley Health Network, Allentown, Pa.
PURPOSE
Preoperative breast MRI is often used as an 
adjunct to mammography and ultrasound to 
guide diagnostic and surgical management 
of breast cancer patients. Given the high 
cost and performance time of MRI, it is 
important to identify which patients would 
benefit most from preoperative MRI 
evaluation. The purpose of our study is to 
assess the value of preoperative MRI in 
characterizing the extent of cancer, identify 
risk factors associated with additional MRI 
lesions not visualized on prior imaging, and 
evaluate the impact on patient management. 
MATERIALS AND METHODS
A retrospective chart review was conducted 
on 199 patients with biopsy-proven breast 
cancer who underwent preoperative MRI 
between January 2014 and February 2018. 
We evaluated the accuracy of MRI at predicting 
the extent of disease, the frequency of 
additional lesions detected on MRI, and the 
changes in surgical management. Statistical 
analysis of associated risk factors was 
performed with the Chi-Square test and 
Fisher’s exact test, with a P-value <0.05 
considered statistically significant.
RESULTS
The cohort included 199 patients with 
known breast cancer, with a median age of 
52 and range of 33-79. The sensitivity of 
MRI in detecting breast cancer was 98%. 
MRI predicted tumor size within 10 mm of 
the pathological tumor size in 155 (78%) 
patients. 72 (36%) MRIs detected additional 
lesions, which led to additional biopsy-
proven sites of cancer in 37 (19%) patients. 
Surgical management was altered in 33 
(17%) patients from either a lumpectomy to 
mastectomy, or mastectomy to bilateral 
mastectomy. Younger age (<50 years) was 
associated with increased frequency of 
additional lesions detected on MRI (P = 
0.004). Risk factors such as race, breast 
density, histopathology, hormone receptor 
status, and BRCA positivity did not have a 
significant association with additional lesions 
detected on MRI. 
CONCLUSION
Preoperative MRI is a useful adjunct to con-
ventional breast imaging in characterizing 
the extent of breast cancer and detecting 
additional lesions, particularly in younger 
patients, resulting in clinically relevant 
changes in patient management.
Figure 1. Detection of additional lesion on breast MRI. 
Right mediolateral oblique (a) and craniocaudal (b) views of a mammogram 
from an outside institution demonstrated a right breast mass at 12 o’clock. 
Right breast ultrasound from the same day (c) redemonstrated this mass, 
located 5 cm from the nipple, found to be invasive ductal carcinoma. Sagittal 
(d) and axial (e, f) MRI images from our institution showed an additional mass 
at 1 o’clock, approximately 7-8 cm from the nipple. Second-look ultrasound 
confirmed the presence of this additional mass. Subsequent ultrasound-
guided core biopsy of this mass demonstrated an additional focus of invasive 
ductal carcinoma. 
TABLE 1. RISK FACTORS ASSOCIATED WITH ADDITIONAL 
LESIONS ON MRI 




<50 46 (58.2) 33 (41.8)
≥50 45 (37.5) 75 (62.5)
Race 0.8642a
White 75 (45.5) 90 (54.6)
Non-white 16 (47.1) 18 (52.9)
Breast Density 0.5807b
Low density 26 (41.9) 36 (58.1)
High density 63 (47.0) 71 (53.0)
Density cannot  
be determined 2 (66.7) 1 (33.3)
Type of Breast Cancer 0.6504b
IDC 66 (46.5) 76 (53.5)
ILC 20 (41.7) 28 (58.3)
Mixed ILC/ID 3 (75.0) 1 (25.0)
Other 2 (40.0) 3 (60.0)
Hormone Receptor Statusc 0.4048b
ER/PR+ 85 (47.0) 96 (53.0)
HER2+ 10 (38.5) 16 (61.5)
Triple negative 2 (25.0) 6 (75.0)
BRCA Positivity 0.6618b
Positive 3 (60.0) 2 (40.0)
Negative 88 (45.4) 106 (54.6)
Data are n(%) unless otherwise stated; percentages might not add to 100% due to rounding.
aChi-Square test was used to calculate p-value
bFisher’s exact test was used to calculate p-value
cN for analysis was 215; additional findings n=97, no additional findings n=118
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